Piperacillin and Tazobactam NDC 65219-434

NDC codes

FDA NDC Directory

Product NDC (as listed)65219-434Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65219-0434Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65219-434-20	65219043420	10 VIAL, SINGLE-DOSE in 1 CARTON (65219-434-20) / 10 mL in 1 VIAL, SINGLE-DOSE (65219-434-02)Marketed from Mar 20, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Piperacillin and Tazobactam
Generic name (nonproprietary): piperacillin and tazobactam
Active ingredients: Piperacillin sodium — 2 g/10mLTazobactam sodium — .25 g/10mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203719
Marketing start: Mar 20, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Penicillins (Chemical structure)beta Lactamase Inhibitors (Mechanism)
Identifiers: Product ID 65219-434_76af03be-bc73-40f9-bde0-31fe9c359ca2SPL ID 76af03be-bc73-40f9-bde0-31fe9c359ca2SPL set ID a798faf5-cd97-4e35-a700-94c372978c46RxCUI 1659131, 1659137, 1659149UNII UXA545ABTT, M98T69Q7HP
Pharmacologic class: Penicillin-class Antibacterial; beta Lactamase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N465219043420 followed by a unit qualifier and the quantity

Package 65219-0434-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 14, 2025.

Indications (excerpt from the label)

Piperacillin and tazobactam for injection is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of: • Intra-abdominal infections in adult and pediatric patients 2 months of age and older ( 1.1 ) • Nosocomial pneumonia in adult and pediatric patients 2 months of age and older ( 1.2 ) • Skin and skin structure infections in adults ( 1.3 ) • Female pelvic infections in adults ( 1.4 ) • Community-acquired pneumonia in adults ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of piperacillin and tazobactam for injection and other antibacterial drugs, piperacillin and tazob…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203719

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203719
Product	Strength	Form · route	Labeler	Product NDC
Piperacillin and Tazobactam	Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	65219-259
Piperacillin and Tazobactam	Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	65219-259
Piperacillin and Tazobactam	Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	65219-436
Piperacillin and Tazobactam	Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-982
Piperacillin and Tazobactam	Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-981
Piperacillin and Tazobactam	Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-981
Piperacillin and Tazobactam	Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-983
Piperacillin and Tazobactam	Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-982
Piperacillin and Tazobactam	Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-983